Exelon (EXC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
Exelon (EXC) reported $6.71 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 11.1%. EPS of $0.92 for the same period compares to $0.69 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $6.45 billion, representing a surprise of +4.05%. The company delivered an EPS surprise of +8.24%, with the consensus EPS estimate being $0.85.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Exelon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Operating revenues- PECO: $1.33 billion versus the three-analyst average estimate of $1.17 billion. The reported number represents a year-over-year change of +26.5%. Operating revenues- ComEd: $2.07 billion versus the three-analyst average estimate of $2.27 billion. The reported number represents a year-over-year change of -1.4%. Operating revenues- BGE: $1.55 billion compared to the $1.33 billion average estimate based on three analysts. The reported number represents a change of +19.8% year over year. Operating revenues- PHI: $1.78 billion versus the three-analyst average estimate of $1.69 billion. The reported number represents a year-over-year change of +10.7%. Electric revenues- ACE: $373 million compared to the $403.80 million average estimate based on two analysts. The reported number represents a change of +4.2% year over year. Electric revenues- DPL: $460 million versus $435.86 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.8% change. Electric revenues- BGE: $1.01 billion compared to the $911.98 million average estimate based on two analysts. The reported number represents a change of +14.9% year over year. Electric revenues- PECO: $956 million versus the two-analyst average estimate of $928.30 million. The reported number represents a year-over-year change of +22.3%. Electric revenues- ComEd: $2.07 billion versus the two-analyst average estimate of $2.31 billion. The reported number represents a year-over-year change of -1.4%. Electric revenues- Pepco: $859 million versus $811.77 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.2% change. Adjusted Operating Earnings (non-GAAP)- ComEd: $325 million versus $305.13 million estimated by two analysts on average. Adjusted Operating Earnings (non-GAAP)- PHI: $194 million compared to the $193.98 million average estimate based on two analysts. View all Key Company Metrics for Exelon here>>>Shares of Exelon have returned +2% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelon Corporation (EXC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Exelon und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Exelon
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Exelon
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Exelon Corp.
Analysen zu Exelon Corp.
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Exelon Overweight | Barclays Capital | |
24.07.2018 | Exelon Sector Outperform | Scotia Howard Weil | |
23.01.2018 | Exelon Neutral | Mizuho | |
15.05.2017 | Exelon Buy | UBS AG | |
13.10.2016 | Exelon Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Exelon Overweight | Barclays Capital | |
24.07.2018 | Exelon Sector Outperform | Scotia Howard Weil | |
15.05.2017 | Exelon Buy | UBS AG | |
24.03.2016 | Exelon Overweight | Barclays Capital | |
07.03.2016 | Exelon Buy | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2018 | Exelon Neutral | Mizuho | |
13.10.2016 | Exelon Neutral | UBS AG | |
13.01.2016 | Exelon Neutral | UBS AG | |
17.11.2015 | Exelon Sector Perform | Scotia Howard Weil | |
26.08.2015 | Exelon Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2012 | Exelon sell | UBS AG | |
12.09.2012 | Exelon sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Exelon Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen